We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Alamy Stock Photo

Fifth Covid-19 vaccine approved for use in Ireland

It is expected that it will be added to Ireland’s booster programme next month.

A FIFTH COVID vaccine has been approved for use in Ireland. 

The Nuvaxovid vaccine, created by US-based Novavax, will now be included in Ireland’s booster vaccination programme for people aged 18 years and older.

Health Minister Stephen Donnelly said the vaccine “has been shown to be highly effective in preventing symptomatic, moderate and severe disease” and he expects it to be available next month. 

The vaccine is given in two doses with an interval of three weeks between doses.  

It was recommended by the National Immunisation Advisory Committee (NIAC) to the Chief Medical Officer, who has endorsed the plans.

The recommendations have been accepted by Donnelly this evening.

“I would urge the small number of people who have yet to come forward for a primary course of a COVID-19 vaccine to do so,” Donnelly said. 

The vaccine had already been granted conditional marketing authorisation by the European Medicines Agency.  

Donnelly added: “This particular vaccine, Nuvaxovid, is a spike protein-based vaccine, and is the first COVID-19 vaccine to be approved that is based on that used in existing vaccines with which we are very familiar including Hepatitis B and whooping cough.

“This vaccine will also be suitable for those individuals who could not avail of another COVID-19 vaccine because of a medical contra-indication e.g. allergic reaction.” 

“The evidence also shows that those who have been boosted are less susceptible to infection and, if infected, are less infectious to others, compared with those who have not been boosted.”

Your Voice
Readers Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel